array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "Gsk Consumer Health, Inc." ["slug"]=> string(32) "4abba-us-gsk-consumer-health-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204" ["description"]=> string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company." ["address_street"]=> string(28) "184 Liberty Corner Rd Ste 78" ["address_place"]=> string(6) "Warren" ["address_region"]=> string(10) "New Jersey" ["founding_date"]=> string(10) "1994-02-28" ["website_domain"]=> string(7) "gsk.com" ["website_url"]=> string(19) "https://www.gsk.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(300) ["article_count"]=> int(497) } ["articles"]=> array(6) { [0]=> array(7) { ["title_en"]=> string(69) "Scientists harness food by-products to fight antimicrobial resistance" ["snippet_en"]=> string(292) "Scientists are embarking on a £1.1 million project aimed at revolutionising drug production by using food by-products to develop new antimicrobial drugs.Led by the University of Strathclyde in collaboration with the University of Surrey and GSK, the research endeavours to make antimicrobial" ["url"]=> string(108) "https://www.wionews.com/science/scientists-harness-food-by-products-to-fight-antimicrobial-resistance-701123" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2181e756-9b70-44f2-a0c2-27e8a8cfe02a" ["source"]=> string(11) "wionews.com" ["publication_date"]=> string(10) "2024-03-17" ["categories"]=> array(3) { [0]=> string(13) "Collaboration" [1]=> string(5) "R & D" [2]=> string(17) "Academic Research" } } [1]=> array(7) { ["title_en"]=> string(62) "“‘Low molecule collagen peptide’ promotes hair growth”" ["snippet_en"]=> string(620) "Research results have shown that 'Low Molecular Weight Collagen Peptide (LMWCP)', which is widely used to improve skin and joint health, is also effective in promoting hair growth. A research team led by Professor Beomjun Kim of the Department of Dermatology at Chung-Ang University Hospital (Director Jeongtaek Kwon) ( Dr. Kim Yu-jin and Dr. Lee Jeong-ok from the Department of Dermatology at Chung-Ang University recently published a research paper proving the hair growth promoting effect of low molecular weight collagen peptide (Low Molecular Weight Collagen Peptide (LMWCP) Promotes Hair Growth by Activating the W" ["url"]=> string(62) "http://www.docdocdoc.co.kr/news/articleView.html?idxno=3015236" ["image_url"]=> string(78) "https://images.businessradar.com/articles/56e86087-9b26-4777-b1b4-ba31222a61f0" ["source"]=> string(15) "docdocdoc.co.kr" ["publication_date"]=> string(10) "2024-03-11" ["categories"]=> array(2) { [0]=> string(18) "Ecological Impacts" [1]=> string(17) "Academic Research" } } [2]=> array(7) { ["title_en"]=> string(92) "The GSK chair of vaccines and global health at the University of Zaragoza begins its journey" ["snippet_en"]=> string(173) "The presentation event took place this Wednesday in the Paraninfo and includes experts such as Inmaculada Cuesta, secretary of the National Nursing and Vaccines Association." ["url"]=> string(116) "https://www.heraldo.es/noticias/aragon/2023/11/16/catedra-gsk-vacunas-salud-global-universidad-zaragoza-1691482.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3dc4fb74-8d1a-494e-8630-d99233ee7445" ["source"]=> string(10) "heraldo.es" ["publication_date"]=> string(10) "2023-11-16" ["categories"]=> array(3) { [0]=> string(5) "Event" [1]=> string(17) "Academic Research" [2]=> string(24) "Access and affordability" } } [3]=> array(7) { ["title_en"]=> string(44) "DEUTSCHE BANK RESEARCH upgrades GSK to 'Buy'" ["snippet_en"]=> string(259) "09/12/2023 - Deutsche Bank Research has kept GSK at 'Buy' with a price target of 1,700 pence. Since its upgrade in March, the pharmaceutical company's shares have had a difficult time and some of its expectations at the time have not been fulfilled, wrote ..." ["url"]=> string(88) "https://www.wallstreet-online.de/nachricht/17325834-deutsche-bank-research-stuft-gsk-buy" ["image_url"]=> string(78) "https://images.businessradar.com/articles/df4a7b5f-64a9-4e22-a557-aa66e8eefe22" ["source"]=> string(20) "wallstreet-online.de" ["publication_date"]=> string(10) "2023-09-12" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(17) "Academic Research" } } [4]=> array(7) { ["title_en"]=> string(46) "GSK Uses Apple ResearchKit In Rheumatoid Study" ["snippet_en"]=> string(277) "

As the chief medical officer at GSK, Murray Stewart spends most of his time focused on patients. A recent PARADE (Patient Rheumatoid Arthritis Data from the Real World) study, launched last year, was the first time GSK attempted to use Apple ResearchKit in a clinical study." ["url"]=> string(86) "https://www.clinicalleader.com/doc/gsk-uses-apple-researchkit-in-rheumatoid-study-0001" ["image_url"]=> string(78) "https://images.businessradar.com/articles/92b9f259-2764-41b6-ae2e-736b6ce26246" ["source"]=> string(18) "clinicalleader.com" ["publication_date"]=> NULL ["categories"]=> array(2) { [0]=> string(5) "R & D" [1]=> string(17) "Academic Research" } } [5]=> array(7) { ["title_en"]=> string(64) "GSK’s ViiV, Exavir Settle Suit on HIV-Drug Compounds Licensing" ["snippet_en"]=> string(273) "ViiV Healthcare and Exavir Therapeutics ended a lawsuit over allegations that Exavir’s patent-licensing agreement with the University of Nebraska on long-acting HIV therapy compounds interfered with the GlaxoSmithKline unit’s research collaboration with the university." ["url"]=> string(97) "https://news.bloomberglaw.com/ip-law/gsks-viiv-exavir-settle-suit-on-hiv-drug-compounds-licensing" ["image_url"]=> string(78) "https://images.businessradar.com/articles/0c046181-9559-4fd5-9441-3c9595fd972a" ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> NULL ["categories"]=> array(2) { [0]=> string(5) "Legal" [1]=> string(17) "Academic Research" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(33) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(28) } [2]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(27) } [3]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(24) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(20) } [5]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(20) } [6]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(20) } [7]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(18) } [8]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(18) } [9]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(16) } [10]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(14) } [11]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(13) } [12]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(13) } [13]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(12) } [14]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(11) } [15]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(10) } [16]=> array(2) { ["name"]=> string(6) "Crisis" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(9) } [19]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(9) } [20]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(8) } [21]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(6) } [27]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(6) } [28]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(6) } [29]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(6) } } } 4abba-us-gsk-consumer-health-inc